MedPath

Influence of Manual Diaphragm Release on Pulmonary Functions in Women With COVID-19

Not Applicable
Completed
Conditions
COVID-19 Pneumonia
Interventions
Other: breathing exercise and prone position alone
Other: manual therapy
Registration Number
NCT05903144
Lead Sponsor
Cairo University
Brief Summary

Manual noninvasive respiratory techniques gained interest to treat respiratory pathologies related to COVID 19. This study designed to determine the combined effect of manual diaphragmatic release technique with the effect of conventional breathing exercises and prone positioning on pulmonary function parameters (FVC, FEV1, PEF, FEV1/FVC, FEF25, FEF50, FEF75, FEF25/75).

Detailed Description

Forty females were randomly assigned to two groups. Group A received manual diaphragm release with conventional breathing exercises and prone positioning. Group B received conventional breathing exercises and prone positioning. Both groups took their prescribed medications. Their ages ranged from 35 to 45 years and with moderate COVID-19 illness. Any cases with mild and severe COVID-19 illness, ICU admission, and chest diseases were excluded.

Main measures: pulmonary function parameters (FVC, FEV1, PEF, FEV1/FVC, FEF25, FEF50, FEF75, FEF25/75).

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
40
Inclusion Criteria
  • women with moderate COVID-19 illness diagnosed by a physician.
  • Patients with o2 saturation >94%Nonsmoker subjects.
  • age ranging from 35-45 years.
  • body mass index from 25 to 34 kg/m2.
Exclusion Criteria
  • Unstable hemodynamic status.
  • Acute respiratory failure requiring intubation and impaired consciousness.
  • Inability to collaborate with prone positioning with refusal.
  • Change of mental status hindering response to instructions.
  • Poorly controlled hypertension (Mean systolic BP > 140 mmhg and \or diastolic BP > 40 mmhg).
  • Patients who take continuous o2 supplementation.
  • Smoking.
  • Other chest diseases as (COPD-asthma-tuberculosis-cancer).
  • Male patients.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control groupbreathing exercise and prone position alonethey received conventional breathing exercises and prone positioning alone in addition to their prescribed medications.
Study groupmanual therapythey received manual diaphragm release with conventional breathing exercises and prone positioning in addition to their prescribed medications.
Study groupbreathing exercise and prone position alonethey received manual diaphragm release with conventional breathing exercises and prone positioning in addition to their prescribed medications.
Primary Outcome Measures
NameTimeMethod
forced vital capacity FVCpre study and 3 weeks post study for all participants

the amount of air that can be forcibly exhaled from your lungs after taking the deepest breath possible which is a common breathing test to check lung function.

FEV1/FVCpre study and 3 weeks post study for all participants

FEV1/FVC, also known as FEV1%) can help distinguish obstructive and restrictive lung diseases.

FEV1pre study and 3 weeks post study for all participants

the maximum amount of air that the subject can forcibly expel during the first second following maximal inhalation

PEFpre study and 3 weeks post study for all participants

show the amount and rate of air that can be forcefully breathed out of the lungs.

PEF25%pre study and 3 weeks post study for all participants

Peak expiratory flow at 25% of fvc and the most sensitive measure of airflow in peripheral airways where primary airflow obstruction originates.

PEF50%pre study and 3 weeks post study for all participants

Peak expiratory flow at 50% ofFVC

PEF 75%pre study and 3 weeks post study for all participants

Peak expiratory flow at 75% of FVC

PEF 25%/75%pre study and 3 weeks post study for all participants

Maximum flow rate in the middle 50% of forced expiration.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Cairo Univeristy

🇪🇬

Multiple Locations, Giza, Egypt

© Copyright 2025. All Rights Reserved by MedPath